56 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • Respiratory Monitoring
  • Market Size

Students are also demonstrated the examination of gastrointestinal endoscopy.

  • Healthcare
  • Managed Care
  • Medical Education
  • World
  • Market Size

Bile acid sequestrates lead to side effects related to the gastrointestinal tract.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • WELCHOL SWOT ANALYSIS, 2015

PLOS ONE; ##(##): ##-##.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • The Medicines Company

ORAL MEDICATIONS THAT INCLUDE ANTIBIOTICS AND RETINOIDS HAVE LED TO INCREASED HEPATOTOXICITY, GASTROINTESTINAL ISSUES AND SUICIDAL TENDENCIES, ALONG WITH THE ABOVE MENTIONED ISSUES.

  • Cholesterol
  • Dermatological Treatment
  • World
  • Forecast
  • Allergan plc

Scope of Business: ##.

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • China
  • Xian-Janssen Pharmaceutical Ltd.

We are one of the nation' s Top ## health systems.

  • Managed Care
  • United States
  • Company
  • Supply
  • GlobalData's company

Scope of Business: ##.

  • Cholesterol
  • Dermatological Treatment
  • China
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Dermatological Treatment
  • Managed Care
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

Drivers and their Impact Impact on Key Customer Category Increase in Incidence of High Cholesterol Increase in Prevalence of Chronic Diseases Changes in Cholesterol Treatment Guidelines Increase in Aging Population Expected Entry of Cost- Effective OTC Versions ## ## ## ## ## Hospitals Low Low

  • Cholesterol
  • Dermatological Treatment
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • Managed Care
  • United States
  • Covidien plc
  • Smith & Nephew Plc

S##. and Rehabilitation; ##(##): ##-##.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SMALL MOLECULE TO ANTAGONIZE GABAA RECEPTOR FOR METABOLIC, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS - DRUG PROFILE
  • DYSLIPIDEMIA - PIPELINE BY SJT MOLECULAR RESEARCH SL, H1 2018

Dyslipidemia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H1 2018, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation...

  • Cholesterol
  • Chronic Disease
  • Managed Care
  • Pharmaceutical
  • Amarin Corporation plc
  • PRASCO LABS ENTERS INTO CO-MARKETING AGREEMENT WITH SHIRE FOR CARBATROL

GlobalData Prasco LLC, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Dermatological Treatment
  • Pharmaceutical
  • United States
  • M&A
  • Prasco, LLC
  • DYSLIPIDEMIA - PIPELINE BY JW PHARMACEUTICAL CORP, H2 2017
  • DYSLIPIDEMIA - PIPELINE BY KOTOBUKI PHARMACEUTICAL CO LTD, H2 2017

The company offers products for cardiovascular, gastrointestinal, nephrology or antianaemic, anticancer and neuropsychiatry.

  • Cholesterol
  • Chronic Disease
  • United States
  • World
  • Product Initiative
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Cholesterol
  • Clinic
  • Dermatological Treatment
  • Managed Care
  • GlobalData's company
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

Dialysis treatments increased by ##%.

  • Healthcare
  • Managed Care
  • United States
  • Company Financials
  • Fresenius Group

BUTYRIC ACID HAS A PROLIFERATIVE EFFECT ON MUCOSAL CELLS IN THE INTESTINE AND PROTECTS THE GASTROINTESTINAL TRACT.

  • Cholesterol
  • Digestive System Disorder
  • Managed Care
  • United States
  • Product Initiative
  • Aug 11, 2017: Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Clinical Trials

Inhibition of Niemann-Pick C##-Like ## (NPC##L##) by ezetimibe results in reduced absorption of cholesterol from the gastrointestinal tract, thereby reducing delivery of cholesterol to the liver, which in turn upregulates LDL receptors.

  • Cholesterol
  • Therapy
  • United States
  • Corporate Finance
  • Esperion Therapeutics, Inc.

One unit is one oximeter sensor.

  • Managed Care
  • Respiratory Monitoring
  • United States
  • Company
  • GlobalData's company
  • HS-25 - Drug Profile

It is found on the gastrointestinal tract epithelial cells as well as in hepatocytes.

  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • Geisinger Health System - History

In August, GHS established a new, US$##. ## million gastrointestinal suite, Geisinger Community Medical Center.

  • Cholesterol
  • Managed Care
  • United States
  • Company
  • Geisinger Health System
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Clinical Trial
  • Hospital
  • Managed Care
  • Respiratory Monitoring
  • Sensor
  • Phase II - Trial Details
  • R&D Progress Research and Development Brief

It is found on the gastrointestinal tract epithelial cells as well as in hepatocytes.

  • Cholesterol
  • South Korea
  • United States
  • World
  • Product Initiative

The molecules developed by Companies in Phase I, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Dermatological Treatment
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.